IRIS
LUCHETTI GENTILONI, Michele Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.082
EU - Europa 3.415
AS - Asia 3.027
SA - Sud America 691
Continente sconosciuto - Info sul continente non disponibili 257
AF - Africa 206
OC - Oceania 8
Totale 14.686
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.957
SG - Singapore 1.057
VN - Vietnam 620
RU - Federazione Russa 587
IT - Italia 583
CN - Cina 538
BR - Brasile 527
UA - Ucraina 456
SE - Svezia 383
DE - Germania 302
IE - Irlanda 273
HK - Hong Kong 226
FR - Francia 210
DK - Danimarca 163
TR - Turchia 162
GB - Regno Unito 147
FI - Finlandia 141
KR - Corea 90
IN - India 78
CI - Costa d'Avorio 73
BD - Bangladesh 67
CA - Canada 61
AR - Argentina 55
MA - Marocco 54
MX - Messico 40
PL - Polonia 37
IQ - Iraq 30
NL - Olanda 29
ZA - Sudafrica 29
JP - Giappone 28
CO - Colombia 26
EC - Ecuador 25
AT - Austria 23
BE - Belgio 19
ID - Indonesia 19
VE - Venezuela 17
ES - Italia 16
UZ - Uzbekistan 16
MY - Malesia 15
PY - Paraguay 15
SA - Arabia Saudita 14
TN - Tunisia 13
LT - Lituania 12
CL - Cile 11
KE - Kenya 11
PH - Filippine 10
OM - Oman 8
AU - Australia 7
EG - Egitto 7
IL - Israele 6
PK - Pakistan 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
DZ - Algeria 5
JM - Giamaica 5
TW - Taiwan 5
BY - Bielorussia 4
CG - Congo 4
EU - Europa 4
JO - Giordania 4
NI - Nicaragua 4
PE - Perù 4
PT - Portogallo 4
ET - Etiopia 3
GR - Grecia 3
KZ - Kazakistan 3
LB - Libano 3
NP - Nepal 3
PA - Panama 3
RS - Serbia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HR - Croazia 2
KH - Cambogia 2
MD - Moldavia 2
PS - Palestinian Territory 2
SN - Senegal 2
BS - Bahamas 1
CD - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
HU - Ungheria 1
KG - Kirghizistan 1
MT - Malta 1
MU - Mauritius 1
MW - Malawi 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 14.430
Salva come PNG Salva come JPEG
Città #
Ashburn 1.032
Chandler 713
Singapore 630
Jacksonville 474
Dallas 369
Fairfield 306
Dublin 268
San Jose 265
Des Moines 263
Boardman 260
Ho Chi Minh City 222
Hong Kong 214
New York 188
Wilmington 185
Council Bluffs 153
Beijing 150
The Dalles 147
Woodbridge 147
Hanoi 137
Ann Arbor 126
Seattle 121
Houston 116
Lauterbourg 108
Moscow 108
Lawrence 107
Princeton 107
Los Angeles 104
San Mateo 103
Centro 88
Cambridge 75
Abidjan 73
Milan 64
Hefei 54
São Paulo 48
Munich 47
San Diego 47
Helsinki 44
Orem 43
Buffalo 42
Redmond 42
Turin 37
Da Nang 36
London 32
Ancona 31
Warsaw 31
Brooklyn 29
Haiphong 25
Santa Clara 25
Denver 24
Chennai 23
Chicago 23
Turku 23
Atlanta 22
Montreal 22
Rome 22
Frankfurt am Main 21
Guangzhou 20
Rio de Janeiro 20
Washington 19
Johannesburg 18
Norwalk 18
Tokyo 18
Wuhan 18
Brussels 17
Manchester 17
Pune 17
Boston 16
Marche 16
Porto 16
Shanghai 16
Stockholm 16
Phoenix 15
Belo Horizonte 14
Mexico City 14
Amsterdam 13
Hải Dương 13
Miano 13
Poplar 13
Tashkent 13
San Francisco 12
Toronto 12
Columbus 11
Vienna 11
Nuremberg 10
Quito 10
Nairobi 9
Naples 9
Brasília 8
Curitiba 8
Goiânia 8
Guayaquil 8
Hangzhou 8
Indianapolis 8
Istanbul 8
Mumbai 8
Porto Alegre 8
Ankara 7
Baghdad 7
Biên Hòa 7
Can Tho 7
Totale 8.770
Salva come PNG Salva come JPEG
Nome #
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 323
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 192
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 190
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 187
ACCURACY OF DUAL-ENERGY COMPUTED TOMOGRAPHY FOR THE DETECTION OF BONE MARROW EDEMA IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS 187
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 180
Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma 175
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. 174
Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis 174
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 171
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 170
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 169
FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth 167
Successful treatment of a Caucasian case of multifocal Castleman¿s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report 166
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 166
c-MYB transactivates the alpha 2(I) collagen gene. 164
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 164
Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile 161
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 153
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 151
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 151
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 150
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 149
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 149
Activation in vitro of scleroderma skin fibroblasts is sustained by increased generation of free radicals through the NADPH-oxidase pathway. 148
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 147
A new HLA-DRB1*11 allele, DRB1*1144, identified by cloning and sequencing 146
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 145
c-myb but not B-myb upregulates a1(I) and a2(I) collagen genes in fibroblasts 142
A novel HLA-Cw*6 allele Cw*160102, identified by cloning and sequencing. 142
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 142
6. Tenoxicam and ketoprofen level monitoring with high-performance liquid chromatography in patients affected by rheumatoid arthritis 140
Skin Involvement in SARS-CoV-2 Infection: Case Series 139
Certolizumab pegol for the treatment of psoriasis 139
c-myb proto-oncogene is expressed by quiescent fibroblasts and unlike B-myb gene does not correlate with proliferation 138
MR imaging of rheumatoid hand lesions: comparison with conventional radiology in 31 patients 137
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 137
BIOLOGIC THERAPY IN INFLAMMATORY AND IMMUNOMEDIATED ARTHRITIS: SAFETY PROFILE 134
21. The Myb oncogene family of transcription factors: potent regulators of hematopoietic cells proliferation and differentiation. 133
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 132
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 130
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 130
TOSSE STIZZOSA: PRESENTAZIONE ATIPICA DI UNA VASCULITE DEI GRANDI VASI 129
Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung Tumorigenesis. 129
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis 129
5-methylcytosine content of DNA in blood and synovial mononuclear cells and in synovial tissue from patients affected by rheumatic autoimmune disease. 127
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 127
Low number of complement C3B/C4B receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis 126
The long pentraxin PTX3 is a marker of scleroderma fibroblasts activation 126
Dual-energy computed tomography for the detection of sacroiliac joints bone marrow oedema in patients with axial spondyloarthritis 126
Identification of a novel human DRB1*13 allele by sequence-based DRB typing. 125
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 123
MULTICENTER VALIDATION OF THE DETECTION OF ARTHRITIS IN INFLAMMATORY BOWEL DISEASES (DETAIL) QUESTIONNAIRE FOR THE SCREENING OF SPONDYLOARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 123
Stimulatory autoantibodies against PDGF receptors in Scleroderma 122
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 122
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study 121
C-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation 119
Reduction of bcl-2 in T-cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erithematosus 118
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes 118
Dissociation between p93-B-myb and p75-c-myb expression during proliferation and differentiation of human myeloid cells lines 117
Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association 117
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 116
Ha-Ras/ERK1-2 pathway is responsible for oxygen species generation in scleroderma fibroblasts 116
Patient reported outcomes and assessment of the quality of life in a cohort of patients affected by enteropathic spondyloarthritis: results of a monocentric prospective observational study at one year 116
c-myb, but not B-myb, upregulates alfa-1(I) and alfa-2(I) collagen gene expression in fibroblasts 114
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 113
Stimulatory autoantibodies against PDGF receptor in systemic sclerosis 112
Effect of high-doses intravenous immunoglobulin in rheumatoid arthritis 112
Stimulating autoantibodies to PDGF A/B receptor on sera from scleroderma patients 112
SpA and PsA basic and translational research OP0205 Gut Dysbiosis in Patients with HLA-B27+ Ankylosing Spondylitis is Associated with Ileitis, Down-Regulation of Tight Junction Proteins, Increased Serum Levels of LPS and Monocytes Anergy 112
Biologics in inflammatory and immunomediated arthritis 111
Preliminary validation of the Simplified Psoriatic Arthritis Radiographic Score (SPARS) 109
Collagen loss and impaired wound healing is associated with c-Myb deficiency. 107
Scleroderma fibroblasts constitutively express the long pentraxin PTX3. 106
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 106
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 105
Tissue-targeted antifibrotic gene therapy using a transgene driven by the promoter of the human type I collagen gene 105
H-Ras but not K-Ras is responsible for reactive oxygen species generation by scleroderma skin fibroblasts. 104
Stimulatory auto-antibodies to the PDGF receptor in patients with chronic GVHD. 101
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 101
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT Study 100
Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study 100
Oxidative stress in scleroderma - Maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway 100
Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: A review of the literature 100
Dolore Articolare Acuto 99
Vitamin d signaling in gastro-rheumatology: From immuno-modulation to potential clinical applications 98
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 98
The treatment of UCD200 and scleroderma fibroblasts with siRNAs anti-C-MYB blocks type I collagen transcription: Toward a gene therapy of scleroderma 96
Development of a Skin-Humanized Model as a Novel Tool to Investigate the Pathogenesis of Scleroderma 96
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 96
Characterization of a novel allele HLA-CW*160102 95
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 95
High risk low-grade lymphoma: Molecular remission after intensive sequential chemotherapy. 94
Therapeutic approach with IVIG in patients affected by connective tissue disease 93
The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors 93
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 92
Reply 92
HLA-B*4904, a new allele identified in two unrelated individuals from the same Italian region. 91
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes. 89
Unbalance between Ha- and Ki-Ras is responsible for scleroderma fibroblast activation 89
Totale 13.012
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.231
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022804 0 178 32 47 13 56 30 49 50 70 107 172
2022/20231.956 164 216 140 187 137 439 3 101 403 14 114 38
2023/2024924 162 25 49 129 135 215 36 37 6 23 8 99
2024/20251.966 202 186 92 24 105 68 245 59 400 98 228 259
2025/20265.457 380 376 347 594 579 426 927 534 453 407 182 252
2026/2027492 466 26 0 0 0 0 0 0 0 0 0 0
Totale 14.686